Pegaptanib sodium

Key facts

Invented name
Macugen
Active substance
Pegaptanib sodium
Therapeutic area
Ophthalmology
Decision number
P/195/2009
PIP number
Pegaptanib sodium
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Diabetic retinopathy
Route(s) of administration
Intravitreal use
Contact for public enquiries
Applicant: Pfizer Global Research & Development
E-mail: PIP_Enquiries@pfizer.com
Country: United Kingdom
Phone: +44 13046446607
Fax: +44 1304657750
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating